CORT Q4 2019 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$88M+31.5% YoY

Gross Profit

$86M98.4% margin

Operating Income

$35M39.8% margin

Net Income

$29M33.4% margin

EPS (Diluted)

$0.24

QoQ Revenue Growth

+7.8%

Cash Flow

Operating Cash Flow

$48M

Free Cash Flow

$48M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$412M

Total Liabilities

$41M

Stockholders' Equity

$371M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$88M	$67M	+31.5%
Gross Profit	$86M	$65M	+32.5%
Operating Income	$35M	$25M	+40.6%
Net Income	$29M	$22M	+33.5%